EMRZXEmerging Markets Fund - Class Z
Market Updates*
- Going into 2021, we believe vaccination success on top of a benign cocktail of low rates, low inflation and ample liquidity may create a favorable atmosphere for emerging markets.
- At a minimum, we believe style and emphasis change in China/U.S. relations will help headline risk for the asset class.
- Acceleration of digital trends should maintain momentum, but performance may broaden out into a wider landscape of smaller companies and countries, creating potential compelling stock specific opportunities for the true all-cap VanEck Emerging Markets Equity Strategy.
- As COVID-19 unfolded, significant market turbulence disproportionately affected small- and mid-cap stocks in emerging markets, as is often the case in times of heightened risk. As markets normalize, we believe it is reasonable to expect relative outperformance from these smaller stocks.
Market Updates*
- Going into 2021, we believe vaccination success on top of a benign cocktail of low rates, low inflation and ample liquidity may create a favorable atmosphere for emerging markets.
- At a minimum, we believe style and emphasis change in China/U.S. relations will help headline risk for the asset class.
- Acceleration of digital trends should maintain momentum, but performance may broaden out into a wider landscape of smaller companies and countries, creating potential compelling stock specific opportunities for the true all-cap VanEck Emerging Markets Equity Strategy.
- As COVID-19 unfolded, significant market turbulence disproportionately affected small- and mid-cap stocks in emerging markets, as is often the case in times of heightened risk. As markets normalize, we believe it is reasonable to expect relative outperformance from these smaller stocks.
Daily Price as of 04/16/21
| NAV† | DAILY CHANGE |
|---|---|
| $22.86 |  $0.13 / +0.6% |
Class Z Details: EMRZX
| INCEPTION DATE | GROSS/NET EXPENSES1 |
|---|---|
| 1.27%/0.90% |
Fund Literature
Fees & Charges
| CLASS | TICKER | MAXIMUM SALES CHARGE |
MAXIMUM DEFERRED SALES CHARGE |
SERVICE FEES 12B-1 |
|---|---|---|---|---|
| A | GBFAX | 5.75% | 0.00%1 | 0.25% |
| C | EMRCX | 0.00% | 1.00% | 1.00% |
| I | EMRIX | 0.00% | 0.00% | 0.00% |
| Y | EMRYX | 0.00% | 0.00% | 0.00% |
| Z | EMRZX | 0.00% | 0.00% | 0.00% |
1A contingent deferred sales charge for Class A shares of 1.00% for one year applies to redemptions of qualified commissionable shares purchased after April 30, 2012 at or above the $1 million breakpoint level.
Account Minimums
| ACCOUNT TYPE |
MINIMUM INITIAL INVESTMENT |
SUBSEQUENT INVESTMENTS |
|---|---|---|
| Regular Accounts | ||
| Class A, C, Y Shares | $1,000 | $100 |
| Class I Shares | $1,000,000 | $0 |
| Class Z Shares | $0 | $0 |
|
Automatic Investment Plans/ Periodic Purchase Plans |
$0 | $0 |
| Third Party Accounts | ||
|
Including a retirement or pension plan account, or any “wrap fee” account or similar program |
$0 | $0 |
Current Annual Fund Operating Expenses
| CLASS A | CLASS C | CLASS I | CLASS Y | CLASS Z | |
|---|---|---|---|---|---|
| Management Fees | 0.75% | 0.75% | 0.75% | 0.75% | 0.75% |
| Distribution and/or Service (12B-1) Fees | 0.25% | 1.00% | 0.00% | 0.00% | 0.00% |
| Other Expenses | 0.53% | 0.57% | 0.41% | 0.43% | 0.52% |
| Total Annual Fund Operating Expenses (Gross)1 | 1.53% | 2.32% | 1.16% | 1.18% | 1.27% |
| Fees/Expenses Waived or Reimbursed1 | 0.00% | 0.00% | -0.16% | -0.08% | -0.37% |
| Total Annual Fund Operating Expenses After Fee Waiver and/or Expense Reimbursement (Net)1 | 1.53% | 2.32% | 1.00% | 1.10% | 0.90% |